Skip Navigation LinksHome > December 2012 - Volume 32 - Issue 4 > Complex Visual Manifestations of Posterior Cortical Atrophy
Journal of Neuro-Ophthalmology:
doi: 10.1097/WNO.0b013e31826b9454
Original Contribution

Complex Visual Manifestations of Posterior Cortical Atrophy

Reñé, Ramon MD, PhD; Muñoz, Silvia MD; Campdelacreu, Jaume MD, PhD; Gascon-Bayarri, Jordi MD; Rico, Imma MD; Juncadella, Montserrat MD, PhD; Arruga, Jordi MD, PhD

Free Access
Article Outline
Collapse Box

Author Information

Departments of Neurology-Dementia Unit (RR, JC, JGB), Neuropsychology (IR, MJ), and Ophthalmology (SM, JA), Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Spain.

Address correspondence to Ramon Reñé, MD, PhD. Neurology Service. Hospital Universitari de Bellvitge. Feixa Llarga s/n, 08907 L’Hospitalet de Llobregat, Spain; E-mail: ramonrenye@hotmail.com

The authors report no financial or conflicts of interest to disclose.

Collapse Box

Abstract

Abstract: We describe 5 patients with complex visual disturbances in the absence of ocular pathology who were ultimately diagnosed with posterior cortical atrophy (PCA). The presence of visual cortical symptoms, neuroimaging findings and clinical evolution led to the diagnosis 1-5 years after the onset of visual symptoms. Age of onset ranged from 50-66 years. In 3 cases, magnetic resonance imaging (MRI) of the brain demonstrated predominantly right posterior cortical atrophy. The other 2 patients had nonspecific MRI findings but the diagnosis was established given the findings on clinical examination and positron emission tomography (PET). All progressed to global dementia and an autopsy confirmed the diagnosis of Alzheimer disease in one patient. The possibility of PCA should be considered when a patient presents with complex visual symptoms in the absence of ocular pathology. Early neurological assessment may avoid diagnostic delay.

Posterior cortical atrophy (PCA) is a progressive neurodegenerative syndrome, usually of presenile onset, associated with atrophy of the occipital and parieto-occipital cortex (1,2) and clinically characterized by symptoms and signs of cortical visual dysfunction (3,4). Diagnostic criteria have been proposed (Table 1) (1,4). The initial symptoms are usually nonspecific visual complaints that prompt the patient to visit an ophthalmologist (1). When ocular pathology is not found, the diagnosis often is delayed until cognitive deficits are detected or further testing is performed.

Table 1
Table 1
Image Tools
Back to Top | Article Outline

METHODS

Five patients were diagnosed with PCA in the Dementia Unit of the Hospital de Bellvitge in the past 10 years. A retrospective review was done of their medical records. Extensive neuropsychological examination, structural neuroimaging (magnetic resonance imaging and/or computed tomography [CT]), and functional neuroimaging (99Tc-HMPAO single-photon emission computed tomography [SPECT] and/or 18FDG positron emission tomography [PET]) were performed in all patients, and, in 1 patient, neuropathological study was available.

Back to Top | Article Outline

RESULTS

Three men and 2 women aged 50–66 years were included. None of them had a family history of dementia. Clinical findings and examination results are summarized in Table 2. Detailed description of 3 cases is presented.

Table 2
Table 2
Image Tools
Back to Top | Article Outline
Case 1

A 65-year-old woman described problems with her vision over the previous 5 years. She reported difficulty threading a needle, thought there was not enough light in her home and wanted to use brighter light bulbs. Two years later, she began using her left hand less and gave up cooking because she dropped food out of the frying pan. She could not recognize people’s faces and identified her own children only by their voices. She could not find or organize her clothing. Two years ago, the patient decided to see an ophthalmologist. Visual acuity was normal, but a left homonymous hemianopia was found. Visual evoked potentials were normal. Brain CT revealed asymmetric enlargement of the lateral ventricles (Fig. 1). One year ago, she was unable to write, tell time on her watch, make the bed, dress herself, grasp an object, and easily got lost, but she did not complain about her memory.

Fig. 1
Fig. 1
Image Tools

On seeing a neurologist, she reported feeling depressed because she was aware of her deficits. Examination revealed a left homonymous hemianopia, left upper limb neglect and deafferentation, alexia, agraphia, right-left confusion, finger agnosia, bilateral stereoagnosia, sensory extinction, optic ataxia, and mild parkinsonism (Table 2). SPECT showed severe right parietotemporo-occipital hypoperfusion. PCA was diagnosed. She died in an institution 3 years later.

Back to Top | Article Outline
Case 2

A 56-year-old man with visual complaints that had started 1 year earlier was seen by his ophthalmologist. He had difficulties with reading and writing, laid the dishes upside down, could not tell the time, could drive and read road signs, but mounted the curb and entered the car through the wrong door. Visual acuity was 20/25 in both the eyes. The patient could not read any of the Ishihara color plates. Intraocular pressure and funduscopy were normal. Visual field testing demonstrated an incomplete left homonymous hemianopia (Fig. 2).

Fig. 2
Fig. 2
Image Tools

The patient was referred for neurological assessment. On examination, he had right hemineglect and apraxia, without language or memory alterations and a normal physical examination. While brain CT was normal, MRI revealed parieto-occipital atrophy bilaterally (Fig. 3). SPECT showed right parietotemporal hypoperfusion (Fig. 4). Neuropsychological examination 3 years later showed widespread deficits including complete Gerstmann syndrome and prosopoagnosia (Table 2). In the following year, the patient was unable to read or write and had difficulty shaving, getting dressed, or going out alone. Visual acuity did not change, but visual field defects progressed in both left hemifields and reliability indices worsened. Brain MRI showed bilateral fronto-parietal atrophy. The patient also developed disinhibition and personality changes. As a result of the clinical suspicion of Alzheimer disease (AD), he received treatment with donepezil and memantine without improvement.

Fig. 3
Fig. 3
Image Tools
Fig. 4
Fig. 4
Image Tools
Back to Top | Article Outline
Case 4

A 56-year-old woman consulted an ophthalmologist because of progressive vision loss. Visual acuity, color vision, funduscopy, electroretinography, and visual evoked potentials were normal. There was a bilateral visual field constriction, but reliability indices were poor. No specific diagnosis was made, and nonorganic visual field loss was a diagnostic consideration. Two years later, she complained of memory loss and disorientation that was attributed to depression. Brain CT showed diffuse cortical atrophy.

The patient was referred to a neurologist, and neuropsychological evaluation detected frontal dysfunction, apraxia, and apperceptive agnosia. Throughout the following year, she developed memory loss, aphasia, severe depression, anxiety, irritability, and aggressiveness, and she received several antidepressants. SPECT revealed right hemisphere hypoperfusion with the absence of activity in the right parietotemporal region. The following year, she experienced visual hallucinations and cognitive fluctuations. She did not improve with donepezil, and in the last months of her life, there was progressive impairment of memory and orientation, apraxia, aphasia, agnosia, mood disorder, and clinophilia. Neurological examination revealed global rigidity, hypomimia, bradykinesia, and parkinsonian gait. The patient did not use her left hand and required nasoduodenal feeding due to severe dysphagia and buccolingual apraxia. PET showed bilateral parieto-occipital hypometabolism, while MRI revealed temporoparieto-occipital atrophy predominantly on the right. With the onset of cortical visual signs and progression to global dementia, she was diagnosed with PCA and progression to presenile AD. She died of respiratory infection, and neuropathology revealed AD (Braak stage VI) with numerous plaques and tangles predominantly in cortical areas, including primary visual cortex, with the absence of alpha-synuclein.

Back to Top | Article Outline

DISCUSSION

Our patients presented with complex visual symptoms in the absence of ocular pathology. The diagnosis of PCA was made 1–5 years after the onset of symptoms and established by the presence of visual cortical complaints, clinical evolution, and neuroimaging findings, fulfilling many of the clinical criteria proposed by Tang-Wai et al (4) (Table 1). The presenting visual complaints were nonspecific, and as in other case series (4,5), patients initially presented to an ophthalmologist. Unlike typical AD, memory, insight, and judgment were relatively preserved until late in the course, resulting in the failure to recognize PCA. This diagnostic delay has been reported to range between 1 and 9 years (4,5). The differential diagnosis includes Lewy body dementia (LBD), Creutzfeldt-Jakob disease (Heidenhain variant), cerebrovascular disease, and nonorganic visual loss.

The mean age of onset of PCA is earlier than in classical AD (4,5). Onset between 40 and 85 years has been reported, but most cases start between 50 and 60 years (4–7). Almost all cases are sporadic. Some have a familial history of late-onset dementia (5,7) but not of PCA, with the exception of 2 sisters reported by Otsuki et al (8). Our patients had onset ages between 50 and 66 years, and none had a family history of AD.

The spectrum of clinical signs of PCA reflects dysfunction of the dorsal (occipito-parietal) and/or the ventral (occipitotemporal) visual streams or primary visual cortical dysfunction (4,9). Almost a quarter of the patients with PCA develop visual hallucinations (4–6), and some have LBD at autopsy. In case 4, despite the presence of hallucinations and spontaneous parkinsonism, the neuropathological diagnosis was AD.

Approximately half of the patients with PCA eventually complain of intermittent memory loss (6), but this is never a prominent initial feature. In most cases, memory loss develops later in the course of the disease. In neuropsychological studies, PCA patients are significantly more impaired in visual perception, spatial memory, visual attention, and visuospatial reasoning compared to AD patients, who are more impaired in episodic memory (9).

Hemianopic visual field loss is thought to be underdiagnosed (10), probably because visual fields are either tested only by confrontation techniques or perimetric examination is not fully reliable because of attention deficits and apraxia of PCA patients.

MRI typically shows bilateral PCA, predominantly affecting the occipital, parietal, and temporal lobes (11). If MRI appears normal or reveals nonspecific atrophy, voxel-based morphometry studies show a pattern of posterior lobe atrophy compared to controls (7). Cortical atrophy is bilateral but more severe on the right side. In studies comparing patients with PCA to those with typical AD, there is greater atrophy in the right visual association cortex and less in the left hippocampus (11). PET studies also show greater parieto-occipital impairment, also with right predominance (Fig. 5) (12). Frontal lobe involvement, although typical of AD, has been reported in PCA, clinically and with functional neuroimaging. This may be because of the degeneration of the afferent input from the parietal-occipital cortices contributing to ocular apraxia (11,12).

Fig. 5
Fig. 5
Image Tools

Autopsy findings of PCA patients usually show AD-type pathology but of posterior distribution and with hippocampal preservation (4). More rarely, some cases have shown LBD. PCA is a clinical syndrome and may be considered as a rare focal onset variant of AD or LBD, or alternatively regarded as a distinct entity.

No treatments for PCA have been evaluated in clinical trials. Cholinesterase inhibitors are sometimes used, but their effectiveness is unproven.

Back to Top | Article Outline

REFERENCES

1. Mendez MF, Ghajarania M, Peeryman KM. Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer’s disease. Dement Geriatr Cogn Disord. 2002;14:33–40.

2. Victoroff J, Ross GW, Benson DF, Verity MA, Vinters HV. Posterior cortical atrophy. Neuropathologic correlations. Arch Neurol. 1994;51:269–274.

3. Pantel J, Schroder J. Posterior cortical atrophy: a new dementia syndrome or a form of Alzheimer’s disease. Fortschr Neurol Psychiatr. 1996;64:492–508.

4. Tang-Wai DF, Graff-Radford NR, Boeve BF, Dickson DW, Parisi JE, Crook R, Caselli RJ, Knopman DS, Peterson RC. Clinical, genetic, and neuropathological characteristics of posterior cortical atrophy. Neurology. 2004;63:1168–1174.

5. McMonagle P, Deering F, Berliner Y, Kertesz A. The cognitive profile of posterior cortical atrophy. Neurology. 2006;66:331–338.

6. Josephs KA, Whitwell JL, Boeve BF, Knopman DS, Tang-Wai DF, Drubach DA, Jack CR Jr, Petersen RC. Visual hallucinations in posterior cortical atrophy. Arch Neurol. 2006;63:1427–1432.

7. Delgado C, Donoso A. Atrofia cortical posterior. Rev Méd Chile. 2009;137:1482–1487.

8. Otsuki M, Soma Y, Tanaka M, Tanaka K, Tanno Y, Uesugi Y, Tsuji S. [Familial posterior cortical atrophy with visual agnosia and Balint’s syndrome]. No To Shinkei. 1995;47:1185–1190.

9. Aresi A, Giovagnoli AR. The role of neuropsychology in distinguishing the posterior cortical atrophy syndrome and Alzheimer’s disease. J Alzheimers Dis. 2009;18:65–70.

10. Formaglio M, Krolak-Salmon P, Tilikete C, Bernard M, Croisile B, Vighetto A. Homonymous hemianopia and posterior cortical atrophy. Rev Neurol (Paris). 2009;16:256–262.

11. Whitwell JL, Jack CR Jr, Kantarci K, Weigand SD, Boeve BF, Knopman DS, Drubach DA, Tang-Wai DF, Petersen RC, Josephs KA. Imaging correlates of posterior cortical atrophy. Neurobiol Aging. 2007;28:1051–1061.

12. Nestor PJ, Caine D, Fryer TD, Clarke J, Hodges JR. The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer’s disease) with FDG-PET. J Neurol Neurosurg Psychiatry. 2003;74:1521–1529.

© 2012 Lippincott Williams & Wilkins, Inc.

Login